(Q41667359)

6 October 2017

1 reference

title

Current therapeutic trends in therapy for chronic viral hepatitis (English)

1 reference

6 October 2017

1

Liaw YF

0 references

publication date

1 October 1997

1 reference

Journal of Gastroenterology and Hepatology

6 October 2017

1 reference

6 October 2017

12

1 reference

6 October 2017

S346-53

1 reference

6 October 2017

9-10

1 reference

The development of cirrhosis in patients with chronic type B hepatitis: A prospective study

6 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

T-cell--mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. A clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Role of hepatitis C virus in dual and triple hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00520.X

10.1111/J.1440-1746.1997.TB00520.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9407357